Alternate TextTo enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
Home > Inhibitors & Agonists > Others

Others

You can also try the following methods, and our professionals will serve you Customized Consultation
Cat. No. Product Name Field of Application Chemical Structure
DCC0570 Am-0687
Novel potent, selective, and orally bioavailable PI3Kdelta inhibitor
More description
DCC0569 Alx-5670
Potent GlyT-2 antagonist
More description
DCC0568 Alx5406
Prodrug of ALX5407, a selective non-transportable inhibitor of the glycine transporter GlyT1
More description
DCC0567 Alx Antagonist
Novel lipoxin A4 receptor/formyl peptide receptor 2 (ALX/FPR2) antagonist
More description
DCC0566 Alvimopan
Peripherally acting µ-opioid antagonist
More description
DCC0564 Alsterpaullone, 2-cyanoethyl
Novel selective dual inhibitor of Cdk1/cyclin B and GSK-3β
More description
DCC0562 Alrestatin Sodium
Specific inhibitor of aldose reductase
More description
DCC0561 Alpha-tocopherol Phosphate
Prodrug of Vitamin E, modulating atherosclerotic and inflammatory events more efficiently than the unphosphorylated alpha-tocopherol
More description
DCC0560 Alpha-ra-f
Novel modulator of collagen synthesis and matrix metalloproteinases (MMPs) expression levels, boosting collagen synthesis and reducing MMPs expression levels in human fibroblasts without cytotoxicity
More description
DCC0559 Alpha-methylserotonin Creatinine Sulfate
Neurotransmitter; stimulating nicotinic receptors
More description
DCC0558 Alpha-lipoic Acid
One of the most effective antioxidants, being involved in the cellular antioxidant system
More description
DCC0557 Alpha-ketoamide-13b
Novel potent inhibitor of the SARS-CoV-2 Mpro, revealing a pronounced lung tropism and suitability for administration by the inhalative route
More description
DCC0556 Alpha-ethylmescaline
Psychedelic, an analog of mescaline
More description
DCC0555 Alpha-cf3-tmc
Novel inhibitor of JAK2 and STAT5 phosphorylation in response to interleukin-3 without altering STAT5 mobility in SDS-PAGE
More description
DCC0554 Alpha-br-tmc
Novel JAK2/STAT5 inhibitor
More description
DCC0553 Alpha-amplexichromanol
Highly potent, orally effective, and metabolically stable allosteric 5-LOX Inhibitor
More description
DCC0552 Alpha7-pam-3ea
Novel potent type I positive allosteric modulator (PAM) of human α7 nAChR
More description
DCC0551 Allylpyrocatechol
Antioxidant, attenuating collagen-induced arthritis via attenuation of oxidative stress secondary to modulation of the MAPK, JAK/STAT, and Nrf2/HO-1 pathways
More description
DCC0550 Alloxan Hydrate [3237-50-1]
Natural chemical suppressor of mlo-mediated resistance in monocotyledonous barley (Hordeum vulgare) and dicotyledonous Arabidopsis thaliana
More description
DCC0549 Alloswitch-1
Novel allosteric modulator to control endogenous G protein-coupled receptors with light
More description
DCC0548 Allo-ile-isoindoline Hcl
Irreversible and selective dipeptidyl peptidase 8 and 9 (DPP-8/9) inhibitor
More description
DCC0547 Allo-i1e-isoindoline
Irreversible and selective dipeptidyl peptidase 8 and 9 (DPP-8/9) inhibitor
More description
DCC0544 Alk-gw9662
Clickable PPARγ inhibitor
More description
DCC0542 Alk/ros1-in-7d
Potent and selective L1196M ALK and ROS1 dual inhibitor
More description
DCC0541 Aldoxorubicin
Prodrug of the anthracycline antibiotic doxorubicin, binding selectively to the cysteine-34 position of albumin via its maleimide moiety, inhibiting DNA synthesis, and inducing apoptosis
More description
DCC0540 Aldi-6 Hydrochloride
Novel ALDH inhibitor, inhibiting ALDH3A1 activity in SCC4 HNSCC xenografts
More description
DCC0539 Aldi-2
Potent and specific covalent inhibitor of aldehyde dehydrogenases
More description
DCC0538 Alda-89
Novel activator of ALDH3A1
More description
DCC0537 Alcuronium Chloride
Neuromuscular blocking (NMB) agent
More description
DCC0536 Albucidin
Novel nucleoside phytotoxin
More description

Customized Consultation X

Your information is safe with us. * Required Fields.

Your name
Company
Email
Procuct Name
Cat. No.
Remark
Verification code
Please fill out the characters in the picture
X